Invention Grant
- Patent Title: BCMA Antigen binding proteins
-
Application No.: US14967167Application Date: 2015-12-11
-
Publication No.: US10220090B2Publication Date: 2019-03-05
- Inventor: Richard J. Armitage , Michelle Blake , William C. Fanslow, III , Jason Charles O'Neill , Gunasekaran Kannan , Jiangchun Xu , Mark Edward Tometsko
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Lawrence B. Kong
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K45/06 ; A61K39/00 ; C07K16/28 ; A61K39/395 ; A61K31/395 ; A61K47/68
Abstract:
The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
Public/Granted literature
- US20190008974A9 BCMA ANTIGEN BINDING PROTEINS Public/Granted day:2019-01-10
Information query
